The new emerging role of AXL associated with DNA damage, DNA damage response (DDR), and homologous recombination (HR) was further shown in NSCLC, triple-negative breast cancer (TNBC), and head and neck squamous cell carcinoma (HNSCC)16. The gene discussed is AXL; the disease is head and neck squamous cell carcinoma.